mRNA Expressions of Gamma-Glutamyl Transferase
Genes in Different Types of Cancer
                    Sevgi YARDIM-AKAYDIN*,°, Ceren DEVIREN*, Ece MISER-SALIHOGLU*, Emel
                      CALISKAN-CAN*, M.Can ATALAY**
                    * Gazi University, Faculty of Pharmacy, Department of Biochemistry, 06330, Etiler, Ankara, Turkey
                      ** Department of General Surgery, Ankara Oncology Training and Research Hospital, 06200, Demetevler, Ankara, Turkey
                    ° Corresponding Author;
                      Tel: +90-312-2023155
                      Fax: +90-312 2235018
                      E-mail: sevgiy@gazi.edu.tr
                    Summary
                      
                      Measurement of gamma-glutamyl transferase (GGT) activity in
                      serum has been found useful in showing tissue damages. In addition
                      to GGT1, different related genes or sequences in the human genome
                      have been reported in pre-genome studies. Two of them, GGT5 and
                      GGT6, are active genes and have similar nucleotide or amino acid
                      sequence to GGT1. The aim of this study was to evaluate the gene
                      expression of GGTs in different types of cancer. In the current study,
                      GGT1, GGT5, and GGT6 mRNA expressions were measured in
                      normal and tumor tissues of 26 patients with breast, gastric and
                      colorectal cancers, using quantitative RT-PCR method. Serum GGT
                      levels were measured by a spectrophotometric method. While GGT1
                      and GGT5 were expressed in almost all the normal and tumor tissues
                      of the patients, GGT6 expressions were observed in half of both the
                      normal and tumor tissues. In all patients, no significant differences
                      were found in mean mRNA expression levels of GGT1, GGT5 and
                      GGT6 (p>0.05), although GGT1 were higher in tumor tissues than
                      those in the normal tissues. GGT1 was overexpressed in half of the
                      patients (13/26) and these over-expressions were positively correlated
                      with gender (p<0.05) and age (p<0.05). In female patients, serum
                      GGT levels were positively correlated with tumor tissue GGT1
                      (p<0.01) and GGT6 (p<0.05). Mostly increased mRNA expressions
                      for GGT1 and GGT5 in tumor tissues, overexpressions in some,
                      show their roles in carcinogenesis. The results given here may suggest
                      that the tumor GGT1 is mainly responsible for the increase in serum
                      GGT levels in female patients.
					
					  
					  Key Words :
					    Gamma-glutamyl transferase, GGT1, GGT5, GGT6,
					    mRNA expression, cancer